The Cambridge clinic has regulatory approval to triage, treat and discharge patients without a human in the loop. Now it wants to do the same for hip, knee and pelvic-health conditions.
The unusual thing about Flok Health is not that an AI runs a physiotherapy appointment. It is that the NHS has signed off on the AI doing it alone. The Cambridge company holds regulatory approval to diagnose, treat and discharge patients with no clinician watching over the process, and on Wednesday it raised $12.5M to extend that model to more of the body and more of the country.
The oversubscribed Series A is led by AlbionVC, with existing backers Eka VC and Form Ventures and new investor Mercia Ventures. The money will scale Flok’s back-pain service across the UK and fund expansion into three new care pathways, hip and knee pain and women’s pelvic health, all due to launch in the UK this year.
What separates Flok from the broad field of healthcare chatbots is the regulatory standing behind it. The company is the first AI system in Europe to gain Class IIa medical device certification for the autonomous delivery of full care pathways, and the only digital musculoskeletal service approved as a healthcare provider by the UK’s Care Quality Commission.
